Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BACIFERM 50 PREMIX DIN 02230720

Status: Cancelled Post Market
Holder: HOFFMANN-LA ROCHE LIMITED
Molecule: BACITRACIN (BACITRACIN ZINC)

Health Canada record

Active ingredient(s)BACITRACIN (BACITRACIN ZINC) 110 G
Dosage formDrug Premix
RouteOral
ScheduleNON-PRESCRIPTION DRUGS
ClassVeterinary
ATC
Original market date11-Nov-1997
Current status date27-Jul-2000
SourceHealth Canada DPD

Establishment licence of the holder

Hoffmann-La Roche Limited — licence 100006, currently licensed, last inspection rating C (2024-06-25).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing BACITRACIN (BACITRACIN ZINC)

DINProductCompanyFormStrengthStatus
02237196ALBAC 110HUVEPHARMA EOODDrug PremixBACITRACIN (BACITRACIN ZINC) 110 GMarketed
02451026BACITRACIN OINTMENTSAFETEC OF AMERICA INCOintmentBACITRACIN (BACITRACIN ZINC) 500 UNITMarketed
01986023BACIFERM-50 PREMIXCYANAMID CANADA INC.Drug PremixBACITRACIN (BACITRACIN ZINC) 110 GCancelled Post Market
02060833BACITRACIN OINTMENT 500 UNITS/GWELLSPRING PHARMACEUTICAL CANADA CORPOintmentBACITRACIN (BACITRACIN ZINC) 500 UNITCancelled Post Market
02019299VETROPOLYCIN HC ONTJANSSENOintmentBACITRACIN (BACITRACIN ZINC) 400 UNIT; NEOMYCIN (NEOMYCIN SULFATE) 3.5 MG; POLYMYXIN B (POLYMYXIN B) 10000 UNIT; HYDROCORTISONE ACETATE 10 MGCancelled Post Market
02019302VETROPOLYCIN ONTJANSSENOintmentBACITRACIN (BACITRACIN ZINC) 400 UNIT; NEOMYCIN (NEOMYCIN SULFATE) 3.5 MG; POLYMYXIN B (POLYMYXIN B SULFATE) 10000 UNITCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
66401997-02-27New Drug Submission (NDS)
Request a quote for BACIFERM 50 PREMIX

How to read a Canadian DIN record